Australia markets open in 9 hours 53 minutes

Coupang, Inc. (CPNG)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
16.47-0.30 (-1.82%)
As of 10:07AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 29.91B
Enterprise value 28.16B
Trailing P/E 69.88
Forward P/E 28.90
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.36
Price/book (mrq)10.78
Enterprise value/revenue 1.28
Enterprise value/EBITDA 36.93

Trading information

Stock price history

Beta (5Y monthly) 1.39
52-week change 32.88%
S&P500 52-week change 317.42%
52-week high 321.31
52-week low 312.66
50-day moving average 318.16
200-day moving average 316.56

Share statistics

Avg vol (3-month) 36.5M
Avg vol (10-day) 37M
Shares outstanding 51.61B
Implied shares outstanding 61.78B
Float 81.17B
% held by insiders 10.83%
% held by institutions 180.30%
Shares short (14 Sept 2023) 419.87M
Short ratio (14 Sept 2023) 43.69
Short % of float (14 Sept 2023) 41.81%
Short % of shares outstanding (14 Sept 2023) 41.11%
Shares short (prior month 14 Aug 2023) 427.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 June 2023

Profitability

Profit margin 1.94%
Operating margin (ttm)1.88%

Management effectiveness

Return on assets (ttm)2.72%
Return on equity (ttm)17.71%

Income statement

Revenue (ttm)22.07B
Revenue per share (ttm)12.44
Quarterly revenue growth (yoy)15.90%
Gross profit (ttm)4.71B
EBITDA 657M
Net income avi to common (ttm)428.79M
Diluted EPS (ttm)0.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.55B
Total cash per share (mrq)2.55
Total debt (mrq)2.72B
Total debt/equity (mrq)98.13%
Current ratio (mrq)1.19
Book value per share (mrq)1.56

Cash flow statement

Operating cash flow (ttm)1.96B
Levered free cash flow (ttm)764.25M